These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9566815)

  • 21. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs.
    De Vry J; Benz U; Schreiber R; Traber J
    Eur J Pharmacol; 1993 Nov; 249(3):331-9. PubMed ID: 7904565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabidiol reverses the mCPP-induced increase in marble-burying behavior.
    Nardo M; Casarotto PC; Gomes FV; Guimarães FS
    Fundam Clin Pharmacol; 2014 Oct; 28(5):544-50. PubMed ID: 24118015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
    Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA
    Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests.
    Chaouloff F; Durand M; Mormède P
    Behav Brain Res; 1997 Apr; 85(1):27-35. PubMed ID: 9095339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
    Vicente MA; Zangrossi H
    Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon.
    Kleven MS; Koek W
    J Pharmacol Exp Ther; 1996 Feb; 276(2):388-97. PubMed ID: 8632301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test.
    Schreiber R; Brocco M; de Ladonchamps BL; Millan MJ
    Pharmacol Biochem Behav; 1995; 51(2-3):211-5. PubMed ID: 7667330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mCPP-induced anxiety--a potential new method for screening anxiolytic activity.
    Bilkei-Gorzó A; Gyertyán I; Szabados T
    Neurobiology (Bp); 1996; 4(3):253-5. PubMed ID: 9044356
    [No Abstract]   [Full Text] [Related]  

  • 31. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
    Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice.
    Griebel G; Misslin R; Pawlowski M; Vogel E
    Neuroreport; 1991 Oct; 2(10):627-9. PubMed ID: 1756245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
    Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
    Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms.
    Kennaway DJ; Moyer RW
    Brain Res; 1998 Sep; 806(2):257-70. PubMed ID: 9739147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
    Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs.
    Rex A; Voigt JP; Voits M; Fink H
    Pharmacol Biochem Behav; 1998 Mar; 59(3):677-83. PubMed ID: 9512071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological manipulation of ultrasound induced defence behaviour in the rat.
    Beckett SR; Aspley S; Graham M; Marsden CA
    Psychopharmacology (Berl); 1996 Oct; 127(4):384-90. PubMed ID: 8923576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.